Elizabeth Stoner

Dr. Elizabeth Stoner, MD, is an Independent Director at iBio, Inc., a Director & Chief Development Officer at Vascular Pharmaceuticals, Inc., an Entrepreneur Partner at MPM BioImpact LLC and a Member-Governors Board at Albert Einstein College of Medicine, Inc. She is on the Board of Directors at iBio, Inc., Antiva Biosciences, Inc., LIB Therapeutics LLC and Vascular Pharmaceuticals, Inc. Dr. Stoner was previously employed as a Chairman by Arovella Therapeutics Ltd., a Chief Executive Officer by Semma Therapeutics, Inc., an Independent Director by Radius Health, Inc., a Chief Medical & Development Officer by Rhythm Pharmaceuticals, Inc., a Chief Development Officer by Allergan GI Corp., an Independent Director by Momenta Pharmaceuticals, Inc., a Senior VP-Clinical Sciences & Product Development by Merck & Co., Inc., a SVP-Global Clinical Development Operations by Merck Research Laboratories Massachusetts LLC, a Chief Medical Officer by ViraCyte LLC, and an Assistant Professor by Weill Cornell Medical College.
She also served on the board at Metabasis Therapeutics, Inc. and Triplet Therapeutics, Inc. She received her undergraduate degree from Ottawa University (Kansas), a graduate degree from Stony Brook University and a doctorate degree from Albert Einstein College of Medicine, Inc..